Traditionally, therapeutic development has focused on small molecules, but amino acid collaborations are progressively receiving traction. This novel approach involves combining peptides with alternative therapeutic methods to confront intricate disease pathways. By leveraging the unique features of peptidic compounds – such as substantial precis